wp00c3b7a5.gif

 

Shaping the Future of Respite Care

 

Respite Care

 

Knowing the Law on Scooters

 

RESEARCH NEWS

Cannabis Treatment Licensed for MS

MS Tablet Recommended in the USA

 

Shaping the Future of Respite Care

 

The MS Society’s Board of Trustees has announced that the Society will no longer directly provide residential respite care and will instead move to a more personalised system of support, providing people with more choice, control and equitable respite options.

 

The change comes after the year-long Respite Care Review and consultation process, during which more than 1,600 people with MS and their carers contributed their views.

 

The results showed that, while the many people highly regarded the care and support they received at one of the Society’s centres, overwhelmingly they want more individualised services, more choice and holiday-style breaks.

 

As people want more choice and control, the MS Society needs to be in the best position to help people with MS and their families understand what is available and make these choices.

 

To do this, the MS Society will develop its services to ensure that people with MS have access to personalised respite services and short breaks across the whole of the UK.

 

We will focus on providing better information, accrediting other services, giving grants, campaigning for better services and influencing other providers.

 

To achieve these important aims, we need to use our resources in the best possible way to secure the best outcomes for everyone affected by MS across the UK.

 

As a result, the MS Society will no longer directly provide residential respite care.  

 

Plans will now be made to transfer the services of the MS Society’s care centres in England, including Brambles in Horley, to an alternative provider.  Where an organisation can’t be found to take over the centre, closure will be the next step.

 

At the moment, all our centres are open for business and there will be no immediate change.

 

For more information on the Respite Care Review, including the Board Papers, go to:   www.mssociety.org.uk/support_and_services

 

 

RESPITE CARE

wpbc3c0519.png

... we provide short breaks for disabled people and carers in our Centres based around the country. We offer respite care in a holiday environment so not only do we offer 24 nursing care on-call but also excursions in the daytime and entertainment in the evening, Centres have licensed bars, some have indoor pools and we have volunteers to help guests get out and about, so it’s a respite break but in a great, fun environment.

We have a wide range of breaks all year round so if you would like a full brochure get in touch us on 0845 345 1970, or we have loads of information on our website www.vitalise.org.uk

We offer group discounts and the MS Society sponsors over 100 breaks at Vitalise Netley Waterside House near Southampton and Vitalise Sandpipers in the north west, enabling guests to enjoy a break at a cost £100 lower than the standard brochure price.   

Also if you know anyone that needs a break but might find funding it difficult, we can support people with either a direct grant towards the cost of a break or we can direct people to other potential sources of funding.  

If you know of anyone who needs a break it’d be great to speak to you.

Many Thanks

Jim Armstrong

Marketing Manager

 

 

 

Knowing the law on Scooters etc

 

From Department of Transport Website (edited)

 

Class 1 – manual wheelchair, i.e. self propelled or attendant-propelled, not electric.

Class 2 – powered wheelchairs and scooters for footway use only with max speed limit of 4mph.

Class 3 – powered wheelchair and other outdoor powered vehicle, including scooters for use on roads/highways with a max speed limit of 8 mph and facility to travel at 4 mph on footways.

Where can class 3 vehicles be used?

On footpaths, pavements, bridleways and pedestrian areas at a maximum speed of 4 mph.

On most roads at a maximum speed of 8 mph.

They cannot be used on motorways, cycle lanes or bus lanes. Nor is it advisable to use them on unrestricted dual carriageways. If they are a 4 wheeled vehicle they must use an amber flashing light for conspicuity when used on dual carriageways.

Class 3 vehicles can only be used by a disabled person aged 14 or over or by an able bodied person who is demonstrating a vehicle before sale, for training a disable person or moving the vehicle for maintenance or repair.

Having an insurance policy is strongly advised to cover your personal safety, other people’s safety and value of the vehicle.

This is a very edited version of the D.O.T.’s information. To find out more go to their website at www.dft.gov.uk and click on ‘access for disabled people’ or contact them on 020 7944 8300 Mon – Fri 8.30 am – 5.30 pm.

wpfa7ef67b_0f.jpg

 

RESEARCH NEWS

 

Cannabis treatment licensed for MS

 

The first symptom relief drug specifically for people with multiple sclerosis has been licensed by the MHRA (Medicines and Healthcare products Regulatory Agency.)

 

‘Sativex’ is an oral spray made using cannabis extract and is used to help alleviate MS symptoms of spasticity.  The treatment, which has been rigorously trialled over the last six years, can be prescribed by MS specialists and should be delivered as part of a multi-disciplinary symptom management programme, which includes regular physiotherapy and assessments by occupational therapists.

 

Ed Holloway, Head of Care & Services Research at the MS Society said:  “Sativex can help alleviate one of the most distressing symptoms of MS and its licensing is good news for people with progressive forms of the condition for whom drugs and therapies are sparse.  We’d like to see it made available to anybody who might benefit.”

 

It’s thought the treatment is only effective in around 40% of people who take it and it becomes clear within a matter of weeks if it’s not working.

 

What is it?

Sativex (pronounced: sat-iv-ex) is a cannabis-based oral spray that had just been approved for the treatment of spasticity in people with MS.

Who is it for?

People with MS who have symptoms of spasticity.  Current trials have not tested the effectiveness of Sativex in treating neuropathic pain.

How is it administered?

Sativex is sprayed on the under-side of the tongue.  Doses can be adjusted by altering the number of sprays taken.

How does it work?

Sativex contains chemicals that belong to a family of chemicals called cannabanoids.  These chemicals are extracted from the cannabis plant.  It is not known exactly how Sativex works--but it is thought cannabanoids in Sativex can mimic natural pain relievers in our body.  This may improve symptoms related to spasticity.

 

MS tablet recommended in the USA

 

The MS tablet FTY720 (fingolimod) has been recommended by the Food and Drug Administration (FDA) advisory committee in the USA to treat people with relapsing-remitting MS.

 

The announcement gives an indication of what might happen when the decision is made by the equivalent authority in the UK, which is due soon.  If licensed in the UK, FTY720 would be one of the first oral therapies, or tablets, to treat MS.  

wp2f40a5a4.png
wp5935f916.png

 

The MS Society officially became a limited charitable company in February, 2011.  This means the Society now has a limited company number and also a new registered charity number as below.